Results 231 to 240 of about 39,851 (272)

Composite inclusion complexes containing hyaluronic acid/chitosan nanosystems for dual responsive enrofloxacin release.

Carbohydrate Polymers, 2021
In order to overcome treatment difficulty of S. aureus infections, a pH/hyaluronidase dual responsive enrofloxacin-cyclodextrin (β-CD) inclusion complexes (IC) containing hyaluronic acid/chitosan (HA/CS) self-assemble composite nanosystems covered by ...
Yuda Liu, Dongmei Chen, Aoxue Zhang, Man Xiao, Zhenxia Li, Wanhe Luo, Yuanhu Pan, Wei Qu, Shuyu Xie   +8 more
semanticscholar   +1 more source

Controlled release of enrofloxacin by vanillin-crosslinked chitosan-polyvinyl alcohol blends.

Materials Science and Engineering C: Materials for Biological Applications, 2021
In transdermal drug delivery applications uniform drug distribution and sustained release are of great importance to decrease the side effects. In this direction in the present research, vanillin crosslinked chitosan (CS) and polyvinyl alcohol (PVA ...
Ilkay Karakurt, K. Ozaltin, Elif Vargun, Liliana Kučerová, P. Šuly, E. Harea, A. Minařík, K. Štěpánková, M. Lehocký, P. Humpolíček, A. Vesel, M. Mozetič   +11 more
semanticscholar   +1 more source

Degradation of antibiotic enrofloxacin in water by gas-liquid nsp-DBD plasma: Parametric analysis, effect of H2O2 and CaO2 additives and exploration of degradation mechanisms

, 2020
Enrofloxacin (ENRO) is a highly toxic fluoroquinolone antibiotic widely used in a broad spectrum of human activities and therefore increased ENRO levels found in aquatic environments pose serious threats for human and livestock health.
C. Aggelopoulos, S. Meropoulis, M. Hatzisymeon, Z. G. Lada, G. Rassias   +4 more
semanticscholar   +1 more source

Cyclic AMP and biofilms reveal the synergistic proliferation strategy of Pseudomonas aeruginosa and Escherichia coli under the costimulation of high concentrations of microplastics and enrofloxacin.

Science of the Total Environment, 2022
Microplastics (MPs) provide attachment sites for biofilm formation of microorganisms, which can promote their resistance to environmental stress has been proved.
Ruian Wu, Jingyuan Chen, Shuo Liu, Shirokova NIu, Xin-Di Liao, Sicheng Xing   +5 more
semanticscholar   +1 more source

Enrofloxacin‐associated retinal degeneration in cats

Veterinary Ophthalmology, 2001
AbstractObjectiveThe objective of this study was to evaluate the possible relationship between the administration of parenteral enrofloxacin and the onset of acute retinal degeneration in cats. The animals studied included 17 cats that received systemic enrofloxacin and developed retinal degeneration soon thereafter.ProceduresIn this retrospective ...
K N, Gelatt, A, van der Woerdt, K L, Ketring, S E, Andrew, D E, Brooks, D J, Biros, H M, Denis, T J, Cutler   +7 more
openaire   +2 more sources

Pharmacokinetics of enrofloxacin in lactating sheep

Research in Veterinary Science, 2003
The pharmacokinetics of enrofloxacin (ENR) was investigated after its intravenous (iv) and intramuscular (im) administration in six healthy lactating sheep. After iv ENR injection (as a bolus), the elimination half-life (t(1/2beta)), the volume of distribution (Vd(area)), and the area under the concentration vs. time curve (AUC) were 3.30 (0.36)h, 2.91
A, Haritova, L, Lashev, D, Pashov
openaire   +2 more sources

Pharmacokinetic evaluation of enrofloxacin in chickens

British Poultry Science, 1997
1. The pharmacokinetics and bioavailability of enrofloxacin in chickens were investigated following intravenous, intramuscular, subcutaneous and oral administration of 10 mg/kg body weight. A rapid distribution phase was followed by a slower elimination phase. 2. The apparent volume of distribution was 2.2 l/kg.
M I, Abd el-Aziz, M A, Aziz, F A, Soliman, N A, Afify   +3 more
openaire   +2 more sources

Nonlinear toxicokinetics of enrofloxacin in rats

Archives of Pharmacal Research, 2010
The dose-dependent toxicokinetics of enrofloxacin were studied by administering various single subcutaneous doses (5, 10, 20, 40, 70, 100, 150, 200, 300 and 400 mg/kg) in male Sprague-Dawley rats. The blood samples were collected from the tail veins, and the plasma concentration of enrofloxacin was determined by an HPLC-fluorescence detection (FLD ...
Hee, Yi, Myung-Jin, Shin, Soo-Min, Cho, Dong-Goo, Lee, Kyul, Cho, Hee-Jung, Cho, Soo-Jean, Shin, Michael G, Bartlett, Jin-Suk, Kim, Ho-Chul, Shin   +9 more
openaire   +2 more sources

Anti-enrofloxacin antibody production by using enrofloxacin-screened HSA as an immunogen

Journal of Ocean University of China, 2005
A two-step zero-length cross-linking procedure using active esters was successfully adopted for conjugating enrofloxacin (EF) to human serum albumin (HSA). The derived conjugate was characterized by UV spectrum and then used for immunization of BALB/C mice.
Chune Liu, Hong Lin, Limin Cao, Jie Jiang   +3 more
openaire   +1 more source

Pharmacokinetics of enrofloxacin in neonatal kittens

American Journal of Veterinary Research, 2004
AbstractObjective—To determine the pharmacokinetics of enrofloxacin in neonatal kittens and compare the pharmacokinetics of enrofloxacin in young and adult cats.Animals—7 adult cats and 111 kittens (2 to 8 weeks old).Procedure—A single dose of 5 mg of enrofloxacin/kg was administered to adults (IV) and kittens (IV, SC, or PO).
M Alexis, Seguin, Mark G, Papich, Kelly J, Sigle, Nicole M, Gibson, Julie K, Levy   +4 more
openaire   +2 more sources